The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Open accessAbstract
The incidence of many cancer types is significantly reduced in individuals with Down’s syndrome, and it is thought that this broad cancer protection is conferred by the increased expression of one or more of the 231 supernumerary genes on the extra copy of chromosome 21. One such gene is Down’s syndrome candidate region-1 (DSCR1, also known as RCAN1), which encodes a protein that suppresses vascular endothelial growth factor (VEGF)-mediated angiogenic signalling by the calcineurin pathway. Here we show that DSCR1 is increased in Down’s syndrome tissues and in a mouse model of Down’s syndrome. Furthermore, we show that the modest increase in expression afforded by a single extra transgenic copy of Dscr1 is sufficient to confer significant suppression of tumour growth in mice, and that such resistance is a consequence of a deficit in tumour angiogenesis arising from suppression of the calcineurin pathway. We also provide evidence that attenuation of calcineurin activity by DSCR1, together with another chromosome 21 gene Dyrk1a, may be sufficient to markedly diminish angiogenesis. These data provide a mechanism for the reduced cancer incidence in Down’s syndrome and identify the calcineurin signalling pathway, and its regulators DSCR1 and DYRK1A, as potential therapeutic targets in cancers arising in all individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Self-citationVessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
A mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913
Risks of leukaemia and solid tumours in individuals with Down's syndrome
Hasle, H., Clemmensen, I. H., & Mikkelsen, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05264-2 · Cited by 892
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
Yang, Q., Rasmussen, S. A., & Friedman, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08092-3 · Cited by 847
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Arron, J. R., Winslow, M. M., Polleri, A., Chang, C.-P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., et al. (2006) · Nature · doi:10.1038/nature04678 · Cited by 698
Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy
Black, W. C., & Welch, H. G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281706 · Cited by 547
Melero-Martin, J. M., De Obaldia, M. E., Kang, S.-Y., Khan, Z. A., Yuan, L., Oettgen, P., & Bischoff, J. (2008) · Circulation Research · doi:10.1161/circresaha.108.178590 · Cited by 488
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT
Gwack, Y., Sharma, S., Nardone, J., Tanasa, B., Iuga, A., Srikanth, S., Okamura, H., Bolton, D., Feske, S., Hogan, P. G., et al. (2006) · Nature · doi:10.1038/nature04631 · Cited by 397
Yang, J., Rothermel, B., Vega, R. B., Frey, N., McKinsey, T. A., Olson, E. N., Bassel-Duby, R., & Williams, R. S. (2000) · Circulation Research · doi:10.1161/01.res.87.12.e61 · Cited by 354
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes
Olson, L. E., Richtsmeier, J. T., Leszl, J., & Reeves, R. H. (2004) · Science · doi:10.1126/science.1098992 · Cited by 330
Single-copy transgenic mice with chosen-site integration.
Bronson, S. K., Plaehn, E. G., Kluckman, K. D., Hagaman, J. R., Maeda, N., & Smithies, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9067 · Cited by 297
Immunosuppressive Drugs and the Risk of Cancer after Organ Transplantation
Dantal, J., & Soulillou, J.-P. (2005) · New England Journal of Medicine · doi:10.1056/nejme058018 · Cited by 256
Minami, T., Horiuchi, K., Miura, M., Abid, M. R., Takabe, W., Noguchi, N., Kohro, T., Ge, X., Aburatani, H., Hamakubo, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406454200 · Cited by 232
Self-citationFuentes, J. J., Pritchard, M. A., & Estivill, X. (1997) · Genomics · doi:10.1006/geno.1997.4866 · Cited by 191
Down's syndrome: an atheroma-free model?
Murdoch, J. C., Rodger, J. C., Rao, S. S., Fletcher, C. D., & Dunnigan, M. G. (1977) · BMJ · doi:10.1136/bmj.2.6081.226 · Cited by 179
Hesser, B. A., Liang, X. H., Camenisch, G., Yang, S., Lewin, D. A., Scheller, R., Ferrara, N., & Gerber, H.-P. (2004) · Blood · doi:10.1182/blood-2004-01-0273 · Cited by 168
Trisomy represses ApcMin -mediated tumours in mouse models of Down’s syndrome
Sussan, T. E., Yang, A., Li, F., Ostrowski, M. C., & Reeves, R. H. (2008) · Nature · doi:10.1038/nature06446 · Cited by 160
Cancer incidence of persons with down syndrome in Finland: A population‐based study
Patja, K., Pukkala, E., Sund, R., Iivanainen, M., & Kaski, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21518 · Cited by 158
Giuriato, S., Ryeom, S. W., Fan, A. C., Bachireddy, P., Lynch, R. C., Rioth, M. J., van Riggelen, J., Kopelman, A. M., Passegue, E. A., Tang, F. L. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608017103 · Cited by 152
Self-citationTargeted Deletion of the Calcineurin Inhibitor DSCR1 Suppresses Tumor Growth
Ryeom, S. W., Baek, K., Rioth, M. J., Lynch, R. C., Zaslavsky, A., Birsner, A. E., Yoon, S. S., & McKeon, F. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.018 · Cited by 131
Self-citationRyeom, S. W., Greenwald, R. J., Sharpe, A. H., & McKeon, F. (2003) · Nature Immunology · doi:10.1038/ni966 · Cited by 128
Self-citationYao, Y., & Duh, E. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.176 · Cited by 84
Harashima, C., Jacobowitz, D. M., Stoffel, M., Chakrabarti, L., Haydar, T. F., Siarey, R. J., & Galdzicki, Z. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9066-4 · Cited by 45
Self-citationDiabetic retinopathy in Down's syndrome
Fulcher, T., Griffin, M., Crowley, S., Firth, R. G., Acheson, R. W., & O’Meara, N. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.4.407 · Cited by 35
The mapping of transgenes by fluorescence in situ hybridization on G-banded mouse chromosomes
Shi, Y. P., Huang, T., Carlson, E. J., & Epstein, C. J. (1994) · Mammalian Genome · doi:10.1007/bf00356551 · Cited by 31
Cited by
Claesson‐Welsh, L., & Welsh, M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12019 · Cited by 868
Causes and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B., & Pellman, D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 815
NFAT, immunity and cancer: a transcription factor comes of age
Müller, M. R., & Rao, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2818 · Cited by 597
Short- and long-term effects of chromosome mis-segregation and aneuploidy
Santaguida, S., & Amon, A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4025 · Cited by 549
NFAT proteins: emerging roles in cancer progression
Mancini, M., & Toker, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2735 · Cited by 371
Metadata
- Authors
- Baek, K.-H., Zaslavsky, A., Lynch, R. C., Britt, C., Okada, Y., Siarey, R. J., Lensch, M. W., Park, I.-H., Yoon, S. S., Minami, T., Korenberg, J. R., Folkman, J., Daley, G. Q., Aird, W. C., Galdzicki, Z., & Ryeom, S.
- Venue
- Nature
- Published
- 2009-05-20
- Volume
- 459
- Issue
- 7250
- Pages
- 1126-1130
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004599241
- Cited by
- 373
- References
- 29
- FWCI
- 40.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.